HOME >> BIOLOGY >> NEWS
Pall filtration technology verified to remove arsenic from drinking water

1,300 non-community water systems will need to take measures to lower arsenic in their drinking water.

Membrane filtration technology is emerging as the technology of choice for safe drinking water. Large and small communities around the world currently use the Pall Aria System to remove parasites, including cryptosporidia and giardia cysts and oocysts that can contaminate drinking water and adversely affect public health. The new verification enables these communities to remove both arsenic and parasites cost efficiently. The Pall system is also employed by a wide range of industries to clean up wastewater to prevent additional arsenic from entering the drinking water supply.

Unlike other methods of arsenic removal, such as reverse osmosis and adsorption media, membrane filtration offers a less costly and long-term solution. It does not require a major upfront capital investment, high costs to operate or frequent regeneration and purchase of media. The Pall Aria System works by the addition of an iron-based coagulant, such as ferric chloride, to the water. The contaminating arsenic is adsorbed onto positively charged ferric hydroxide particles, which are then removed by microfiltration.

"The arsenic removal verification opens up a whole new market for Pall Water Processing, which is currently one of the fastest growing businesses of Pall Corporation. This past year our sales to municipal and community water systems have grown over 26 percent," adds Mr. Seibert.

Arsenic Hot Spots and Public Health Implications

Arsenic levels across the U.S. can vary greatly. Although there are some geographic hot spots, the highest arsenic levels in the U.S. are found mostly in states west of the continental divide. However, several New England states such as New Hampshire and Maine have reported that as many as 30% and 14%, respectively, of their public water systems have arsenic levels above the new standard.

Arse
'"/>

Contact: Marcia Katz
Marcia_Katz@pall.com
516-801-9128
Pall Corporation
6-Dec-2005


Page: 1 2 3

Related biology news :

1. Carbon capture, water filtration, other boreal forest ecoservices worth estimated $250 billion/year
2. Water filtration technique removes dangerous freshwater algae toxins
3. Pall blood filtration technology removes prions that can cause TSEs
4. AFCYBER holds science and technology symposium
5. New technology reveals seal behavior
6. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
7. FDA Nanotechnology Task Force takes positive step forward
8. Liverpool amongst first in UK to install unique DNA sequencing technology
9. EPA foregoes opportunity to improve nanotechnology oversight
10. The Cancer Genome Atlas awards funds for technology development
11. Autism theory put to the test with new technology

Post Your Comments:
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: